1- (2,3-Dichlorophenyl) piperazine Hydrochloride CAS 119532-26-2 Aripiprazole Intermediate Purity>99.0% (HPLC)

Nkọwa dị mkpirikpi:

Aha: 1- (2,3-Dichlorophenyl) piperazine Hydrochloride

Njikọta: 2,3-DCPP HCl

OZI: 119532-26-2

Dị ọcha:> 99.0% (HPLC)

Ọdịdị: White ma ọ bụ Gbanyụọ-Ọcha ntụ ntụ

Ọkara nke Aripiprazole (CAS: 129722-12-9)

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical 1- (2,3-Dichlorophenyl)piperazine Hydrochloride
Ụdị okwu 2,3-DCPP HCl;1- (2,3-Dichlorophenyl) piperazine HCl;Aripiprazole EP adịghị ọcha B;Njikọ dị na Aripiprazole C
Nọmba CAS 119532-26-2
Nọmba CAT RF-PI2268
Ọnọdụ Ahịa Na Akụrụngwa, Ikike Mmepụta 30 MT / Ọnwa
Usoro ihe omimi C10H12Cl2N2·HCl
Ibu molekụla 267.58
Ebe Na-agbaze 245.0 ~ 247.0 ℃
Nchekwa & Mmetụta Hygroscopic.Okpomọkụ gburugburu
Solubility na Mmiri Soluble na Mmiri
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Ọcha ma ọ bụ Gbanyụọ-Ọcha ntụ ntụ
Ụzọ ịdị ọcha / nyocha > 99.0% (HPLC)
Ọnwụ na ihicha <0.50%
Ihe fọdụrụ na mgbanye <0.10%
Otu adịghị ọcha <0.50%
Mgbakọta adịghị ọcha <1.00%
Ọla dị arọ (dị ka Pb) ≤20ppm
Spectrum infrared Dabara na Ọdịdị
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ọkara nke Aripiprazole (CAS: 129722-12-9)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Hygroscopic.Chekwaa pụọ ​​na mmiri/mmiri na ihe ndị na-eme ihe na-ekpo ọkụ.Debe akpa ahụ nke ọma ma tinye ya na ọnọdụ dị jụụ, kpọrọ nkụ na nke ọma.Chekwaa n'okpuru gas inert

Uru:

1

Ajụjụ:

Ngwa:

1- (2,3-Dichlorophenyl) piperazine Hydrochloride (CAS: 119532-26-2) bụ etiti dị mkpa nke Aripiprazole (CAS: 129722-12-9).Aripiprazole bụ ụdị ọhụrụ nke ihe nrụpụta quinoline soluble lipid nke ukwuu, njirimara ọgwụ ya bụ na ọ bụghị naanị postsynaptic dopamine D 2 antagonist, kamakwa presynaptic dopamine D 2 agonist, ọ nwekwara ike kpalie D 1, D 3, D 4 ndị na-anabata ya;ọ nwere mmetụta abụọ nke ntinye akụkụ ma ọ bụ onye na-anabata ihe na-anabata 5-HT 1A;o nwere ihe mmegide kpamkpam na onye nnabata 5-HT 2A.Njirimara a dị iche na ọgbọ mbụ, yana antipsychotics nke na-ahụ maka ọgbọ nke abụọ nke ọgwụ antipsychotic, ya mere a na-akpọ ya dopamine system stabilizer ma ọ bụ ọgbọ atọ antipsychotic.Ebe ọ bụ na a na-ere ya n'ahịa, a na-ejikarị ya na schizophrenia nke ụlọ ọgwụ, ọgwụgwọ ọrịa na-emetụta mmetụta na ọrịa uche ndị ọzọ.Dị ka akwụkwọ akụkọ si kwuo, aripiprazole nwere mmetụta dị ịrịba ama na schizophrenia nti na mgbaàmà na-adịghị mma na nchekasị, ịda mbà n'obi, ọrụ ọgụgụ isi, ebe nchekwa dị elu.A kọkwara na ọgwụ ahụ nwekwara ike ịgwọ ọrịa uche ndị ọzọ, dị ka nsogbu ọnọdụ uche manic episodes, senile dementia jikọtara na nsogbu uche, nsogbu nchekasị, nsogbu omume ụmụaka, ịda mbà n'obi.N'oge a,Bristol-Myers Squibb na Otsuka Pharmaceutical Company kwupụtara na European Union akwadola Abilify (aripiprazole) na ọgwụgwọ nke ngwa ndepụta schizophrenia.

Dee ozi gị ebe a ziga anyị ya